Skip to main content
. 2019 Feb 14:e186752. Online ahead of print. doi: 10.1001/jamaoncol.2018.6752

Table 1. Patient Completion of Quality-of-Life Assessment Measurements.

Quality-of-Life Measurement CRT Arm, No. (%) (n = 478) HRT Arm, No. (%) (n = 484)
EPIC
Baseline 423 (88.5) 440 (90.9)
6 Months 328 (68.6) 373 (77.1)
12 Months 306 (64.0) 329 (68.0)
24 Months 259 (54.2) 275 (56.8)
60 Months 286 (59.8) 299 (61.8)
HSCL-25
Baseline 378 (79.1) 398 (82.2)
6 Months 298 (62.3) 337 (69.6)
12 Months 288 (60.3) 308 (63.6)
24 Months 237 (49.6) 250 (51.7)
60 Months 271 (56.7) 281 (58.1)
EQ–5D
Baseline 418 (87.4) 439 (90.7)
6 Months 324 (67.8) 371 (76.7)
12 Months 303 (63.4) 322 (66.5)
24 Months 245 (51.3) 259 (53.5)
60 Months 277 (57.9) 287 (59.3)

Abbreviations: CRT, conventional radiotherapy; EPIC, Expanded Prostate Cancer Index Composite questionnaire; EQ–5D, EuroQol–5 Dimension questionnaire; HRT, hypofractionated radiotherapy; HSCL-25, Hopkins Symptom Checklist.